European Academy of Dermatology & Venereology
With over 13'000 members and an active community of more than 17'000 professionals around the world, our goal is to be the trusted source for proven scientific advancements and practices in the prevention, diagnosis, and treatment of skin and venereal diseases.
EADV is committed to building the international community that develops, shares, and adopts best practices within dermatology and venereology.
Skin and venereal diseases are continuously evolving, as are the science and practices for preventing, diagnosing and treating them. Advancements are being made every day that have the potential to have a significant impact on the ongoing battle to improve skin and sexual health around the world. Enabling these advancements to be validated and ensuring all professionals adopt the best practices ultimately moves dermatology and venereology forward.
EADV and its international community of passionate professionals define and spread best practices in dermatology and venereology for the benefit of all. We are a true platform for collaboration and progress across borders and sub-specialties.
Expert task forces shape standards and develop best practice guidelines, while our events, publications, and educational courses share them with our members and the broader community so they can adopt them for maximum impact.
EADV, Together for better
EADV LATEST NEWS:
JEADV Call for Papers: Hidradenitis Suppurativa
We invite manuscript submissions from both academia and industry, with priority given to those demonstrating strong clinical relevance. By sharing these insights, we hope to inspire further research, increase awareness, promote investigation and address critical unmet needs in the field of HS.
Vol 4 Issue 5 of the JEACP is online
See the latest updates from JEADV Clinical Practice (JEACP), our open-access publication focused on clinical content and practical information.
In this issue: Squamous cell carcinoma, sex differencies in nevus count, cutaneous granulomas, plaque-like dermatofibroma, and more.
Vol 39 Issue 12 of the JEADV is online
See the latest updates on skin & venereal diseases from JEADV, our high-ranking international journal.
In this issue: In this issue: AI models, JAK inhibitors, infections associated with dupilumab, and more.